streptonigrin has been researched along with Myeloproliferative Disorders in 1 studies
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YL | 1 |
1 other study available for streptonigrin and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Therapeutic results of chronic leukemia and other myeloproliferative syndrome with streptonigrin in 92 cases (author's transl)].
Topics: Female; Humans; Leukemia; Male; Myeloproliferative Disorders; Streptonigrin | 1980 |